open extension Latest Research Papers

12 Month Open Extension of TNS for ADHD.

Case Medical Research ◽

10.31525/ct1-nct03888391 ◽

2019 ◽

Author(s):

Keyword(s):

Open Extension

Download Full-text

Improvement in Health and Possible Reduction in Disease Activity Using Endurance Exercise in Patients With Established Polymyositis and Dermatomyositis: A Multicenter Randomized Controlled Trial With a 1-Year Open Extension Followup

Arthritis Care & Research ◽

10.1002/acr.22068 ◽

2013 ◽

Vol 65 (12) ◽

pp. 1959-1968 ◽

Cited By ~ 38

Author(s):

Li Alemo Munters ◽

Maryam Dastmalchi ◽

Vivianne Andgren ◽

Christina Emilson ◽

Jenny Bergegård ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Disease Activity ◽

Endurance Exercise ◽

Controlled Trial ◽

Randomized Controlled ◽

Multicenter Randomized Controlled Trial ◽

Open Extension

Download Full-text

Ziprasidone in Adolescents with Schizophrenia: Results from a Placebo-Controlled Efficacy and Long-Term Open-Extension Study

Journal of Child and Adolescent Psychopharmacology ◽

10.1089/cap.2012.0068 ◽

2013 ◽

Vol 23 (8) ◽

pp. 531-544 ◽

Cited By ~ 33

Author(s):

Robert L. Findling ◽

Idil Çavuş ◽

Elizabeth Pappadopulos ◽

Douglas G. Vanderburg ◽

Jeffrey H. Schwartz ◽

...

Keyword(s):

Extension Study ◽

Open Extension

Download Full-text

Faculty Opinions recommendation of Safety and efficacy of deep brain stimulation in refractory cluster headache: a randomized placebo-controlled double-blind trial followed by a 1-year open extension.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.4916981.4847085 ◽

2010 ◽

Author(s):

Thorsten Bartsch

Keyword(s):

Deep Brain Stimulation ◽

Cluster Headache ◽

Brain Stimulation ◽

Double Blind Trial ◽

Double Blind ◽

Safety And Efficacy ◽

Blind Trial ◽

Open Extension ◽

Deep Brain

Download Full-text

P.3.c.010 Risperidone and olanzapine comparison for weight changes in a 24 months open extension study

European Neuropsychopharmacology ◽

10.1016/s0924-977x(10)70680-5 ◽

2010 ◽

Vol 20 ◽

pp. S463

Author(s):

D. Begic ◽

S. Bise ◽

O. Cemalovic

Keyword(s):

Extension Study ◽

Weight Changes ◽

Open Extension

Download Full-text

Commentary on Fontaine et al.: Safety and efficacy of deep brain stimulation in refractory cluster headache: a randomized placebo-controlled double-blind trial followed by a 1-year open extension

The Journal of Headache and Pain ◽

10.1007/s10194-009-0184-5 ◽

2010 ◽

Vol 11 (1) ◽

pp. 21-22 ◽

Cited By ~ 4

Author(s):

Anna Ambrosini ◽

Jean Schoenen

Keyword(s):

Deep Brain Stimulation ◽

Cluster Headache ◽

Brain Stimulation ◽

Double Blind Trial ◽

Double Blind ◽

Safety And Efficacy ◽

Blind Trial ◽

Open Extension ◽

Deep Brain

Download Full-text

Safety and efficacy of deep brain stimulation in refractory cluster headache: a randomized placebo-controlled double-blind trial followed by a 1-year open extension

The Journal of Headache and Pain ◽

10.1007/s10194-009-0169-4 ◽

2009 ◽

Vol 11 (1) ◽

pp. 23-31 ◽

Cited By ~ 151

Author(s):

Denys Fontaine ◽

Yves Lazorthes ◽

Patrick Mertens ◽

Serge Blond ◽

Gilles Géraud ◽

...

Keyword(s):

Deep Brain Stimulation ◽

Cluster Headache ◽

Brain Stimulation ◽

Double Blind Trial ◽

Double Blind ◽

Safety And Efficacy ◽

Blind Trial ◽

Open Extension ◽

Deep Brain

Download Full-text

Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel® therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extension

Pituitary ◽

10.1007/s11102-009-0191-1 ◽

2009 ◽

Vol 13 (1) ◽

pp. 18-28 ◽

Cited By ~ 85

Author(s):

Shlomo Melmed ◽

David Cook ◽

Jochen Schopohl ◽

Miklos I. Goth ◽

Karen S. L. Lam ◽

...

Keyword(s):

Growth Hormone ◽

Growth Factor ◽

Multicenter Study ◽

Insulin Like Growth Factor ◽

Serum Growth Hormone ◽

Sustained Reduction ◽

Open Extension ◽

Lanreotide Autogel

Download Full-text

Effectiveness of reducing infliximab dose interval in non-responder patients with refractory spondyloarthropathies. An open extension of a multicentre study

Rheumatology ◽

10.1093/rheumatology/kei085 ◽

2005 ◽

Vol 44 (12) ◽

pp. 1555-1558 ◽

Cited By ~ 20

Author(s):

E. Collantes-Estevez ◽

M. C. Muñoz-Villanueva ◽

P. Zarco ◽

J. C. Torre-Alonso ◽

J. Gratacós ◽

...

Keyword(s):

Multicentre Study ◽

Dose Interval ◽

Open Extension

Download Full-text

Daily Oral Pamidronate in Women and Men With Osteoporosis: A 3-Year Randomized Placebo-Controlled Clinical Trial With a 2-Year Open Extension

Journal of Bone and Mineral Research ◽

10.1359/jbmr.2002.17.6.1057 ◽

2002 ◽

Vol 17 (6) ◽

pp. 1057-1064 ◽

Cited By ~ 50

Author(s):

Caroline Brumsen ◽

Socrates E. Papapoulos ◽

Paul Lips ◽

Petronella H. L. M. Geelhoed-Duijvestijn ◽

Neveen A. T. Hamdy ◽

...

Keyword(s):

Clinical Trial ◽

Controlled Clinical Trial ◽

Oral Pamidronate ◽

Open Extension

Download Full-text

open extension
Recently Published Documents

TOTAL DOCUMENTS

H-INDEX

12 Month Open Extension of TNS for ADHD.

Improvement in Health and Possible Reduction in Disease Activity Using Endurance Exercise in Patients With Established Polymyositis and Dermatomyositis: A Multicenter Randomized Controlled Trial With a 1-Year Open Extension Followup

Ziprasidone in Adolescents with Schizophrenia: Results from a Placebo-Controlled Efficacy and Long-Term Open-Extension Study

Faculty Opinions recommendation of Safety and efficacy of deep brain stimulation in refractory cluster headache: a randomized placebo-controlled double-blind trial followed by a 1-year open extension.

P.3.c.010 Risperidone and olanzapine comparison for weight changes in a 24 months open extension study

Commentary on Fontaine et al.: Safety and efficacy of deep brain stimulation in refractory cluster headache: a randomized placebo-controlled double-blind trial followed by a 1-year open extension

Safety and efficacy of deep brain stimulation in refractory cluster headache: a randomized placebo-controlled double-blind trial followed by a 1-year open extension

Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel® therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extension

Effectiveness of reducing infliximab dose interval in non-responder patients with refractory spondyloarthropathies. An open extension of a multicentre study

Daily Oral Pamidronate in Women and Men With Osteoporosis: A 3-Year Randomized Placebo-Controlled Clinical Trial With a 2-Year Open Extension

Export Citation Format

open extensionRecently Published Documents

TOTAL DOCUMENTS

H-INDEX

12 Month Open Extension of TNS for ADHD.

Improvement in Health and Possible Reduction in Disease Activity Using Endurance Exercise in Patients With Established Polymyositis and Dermatomyositis: A Multicenter Randomized Controlled Trial With a 1-Year Open Extension Followup

Ziprasidone in Adolescents with Schizophrenia: Results from a Placebo-Controlled Efficacy and Long-Term Open-Extension Study

Faculty Opinions recommendation of Safety and efficacy of deep brain stimulation in refractory cluster headache: a randomized placebo-controlled double-blind trial followed by a 1-year open extension.

P.3.c.010 Risperidone and olanzapine comparison for weight changes in a 24 months open extension study

Commentary on Fontaine et al.: Safety and efficacy of deep brain stimulation in refractory cluster headache: a randomized placebo-controlled double-blind trial followed by a 1-year open extension

Safety and efficacy of deep brain stimulation in refractory cluster headache: a randomized placebo-controlled double-blind trial followed by a 1-year open extension

Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel® therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extension

Effectiveness of reducing infliximab dose interval in non-responder patients with refractory spondyloarthropathies. An open extension of a multicentre study

Daily Oral Pamidronate in Women and Men With Osteoporosis: A 3-Year Randomized Placebo-Controlled Clinical Trial With a 2-Year Open Extension

open extension
Recently Published Documents